2024
Pilot and feasibility studies, (2024).10 1 10.1186/s40814-024-01563-8.
2024
The Lancet. Global health, (2024).13 1 10.1016/S2214-109X(24)00373-5.
Cross-sectional association between female genital schistosomiasis and high-risk human papillomavirus among women of reproductive age in Zambia'.
2024
(2024).
Effect of intermittent preventive treatment of malaria in pregnancy on vaginal microbiota, host immune response and pregnancy outcomes: a case-control study from the ASPIRE trial in Zambia.
2024
(2024).(5); 6834 110
The effect of intermittent preventive treatment of malaria in pregnancy (IPTp) on the maternal intestinal microbiome and its relationship with fetal growth.
2024
(2024).(5); 6457 110
The effect of additional doses of sulfadoxine-pyrimethamine administered as perennial malaria chemoprevention on hemoglobin levels among children in a malaria endemic area of Cameroon.
2024
(2024).8019 110 (5)
2024
BMC public health, (2024).24 1 10.1186/s12889-024-20588-5.
Parasite clearance and protection from plasmodium falciparum infection: clinical results from a three-arm, parallel, double-blinded, placebo-controlled, randomized trial of presumptive sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine plus amo...
2024
(2024).(5); 7189 110
Parasite clearance and protection from plasmodium falciparum infection: clinical results from a two-arm, parallel, double-blinded, placebo-controlled, randomized trial of presumptive sulfadoxine-pyrimethamine versus artesunate monotherapy among asympto...
2024
(2024).(5); 7303 110
